DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Fezolinetant
Fezolinetant
Minilap: a MIGS Approach to the Benign Large Adnexal Mass Surgical Technique Video
Neurokinin Receptor NK Receptor
Stembook 2018.Pdf
Acer Therapeutics Inc. Form 8-K Current Event Report Filed 2021-06
WHO-EMP-RHT-TSN-2018.1-Eng.Pdf
Title Scaffold Hopping of Fused Piperidine-Type NK3 Receptor
OCTOBER 2019 Mrx Pipeline a View Into Upcoming Specialty and Traditional Drugs TABLE of CONTENTS
Fezolinetant: a Novel Approach for Targeted Menopausal Symptom Relief
Edinburgh Research Explorer
Non-Confidential Corporate Presentation
Lääkeaineiden Yleisnimet (INN-Nimet) 31.12.2019
Neurokinin Receptor NK Receptor
REED Vulva LA Tak Due 1-15-16 Vulvar Talk LA January 2016.Pptx 1
Personalizing the Road Ahead for Women Experiencing Vasomotor Symptoms During Menopause Disclaimer Expert Faculty
Vasomotor Symptoms (Ivms) Where Hormone Replacement Therapy (HRT) Is Likely Contraindicated
A Placebo-Contr
A View Into Upcoming Specialty & Traditional Drugs
Drug Repurposing Compound Library (96-Well)
Top View
UPDATE: Astellas's European Screen Yields Ogeda
Effects of NT-814, a Dual Neurokinin 1 and 3 Receptor Antagonist, on Vasomotor Symptoms in Postmenopausal Women: a Placebo- Controlled, Randomized Controlled Trial
Endocrinology Compound Library (96-Well)
A Phase 2B, Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study of the Neurokinin 3 Receptor Antagonist Fezolinetan